The global Aspirin market volume was roughly 41 thousand tonnes in 2023 and is anticipated to grow at a CAGR of 2.5% during the forecast period until 2034.
Aspirin, chemically known as acetylsalicylic acid, is a versatile medication with a range of uses. Primarily recognized as a pain reliever, Aspirin effectively mitigates mild to moderate pain stemming from various sources such as headaches, toothaches, menstrual cramps, and muscle aches. Its analgesic properties make it a household staple for alleviating discomfort. Beyond pain relief, Aspirin serves as a fever reducer, aiding in the management of febrile conditions like colds and flu by lowering body temperature. Additionally, Aspirin exhibits potent anti-inflammatory effects, which are beneficial for mitigating inflammation and swelling associated with conditions like arthritis and other inflammatory disorders. Another critical function of Aspirin is its role as a blood thinner. By inhibiting the formation of blood clots, Aspirin helps prevent conditions such as heart attacks and strokes, particularly in individuals at risk for cardiovascular events. This blood-thinning property also extends to its use in cardiovascular protection, where low-dose Aspirin is often prescribed as a preventive measure against heart disease and stroke. Furthermore, emerging research suggests a potential link between long-term Aspirin use and a reduced risk of colorectal cancer, highlighting its potential in cancer prevention strategies.
The Aspirin market is influenced by several dynamic factors, with notable drivers propelling its growth trajectory. Firstly, the increasing prevalence of cardiovascular diseases worldwide serves as a significant driver for market expansion. With heart attacks and strokes on the rise globally, Aspirin is increasingly utilized both as a therapeutic option and a preventive measure. This trend reflects the growing demand for Aspirin in managing and mitigating cardiac disorders, thus driving market growth. Additionally, the rising geriatric population worldwide is driving the demand for Aspirin. As age-related illnesses, including cardiovascular diseases and arthritis, become more prevalent among the elderly, Aspirin emerges as a cornerstone in their treatment regimen. The growing aging demographic across the globe underscores the future growth prospects of the Aspirin market, as it continues to be a crucial therapeutic option for addressing age-associated health conditions. The global Aspirin market is likely to reach approximately 57 thousand tonnes in 2034.
Geographically, the Asia Pacific region is the largest consumer of Aspirin and is anticipated to witness the highest growth in the global Aspirin market, primarily driven by increasing cardiovascular disease prevalence. As heart health issues become more common due to changing lifestyles and aging populations, the demand for Aspirin as both a treatment and preventive measure is expected to rise. Additionally, improving healthcare infrastructure and rising healthcare spending in countries across the region contribute to increased access to Aspirin. The substantial population base in countries like China and India further fuels market growth, coupled with growing awareness of Aspirin's benefits in cardiovascular health. Furthermore, ongoing advancements in pharmaceutical research and development in the Asia-Pacific region enhance the efficacy and safety of Aspirin formulations, fostering greater adoption and driving market expansion.
Based on end-use applications, the global Aspirin market is divided into Pain and Fever, Cardiovascular Disease, and Others. Among these industries, Pain and Fever is the major application. Aspirin is used as a pain reliever for headaches, muscle aches, and other mild to moderate pain conditions. It is also effective in reducing fever related with cold and flu.
Major players in the Global Aspirin market are Allegiant Health, Bayer AG, Dr Reddy's Laboratories, Globalimporter Inc., JQC (Huayin) Pharmaceutical Co. Ltd., Cardinal Health, Par Pharmaceutical, Industria Quimica Andina Y Cia Sa, Perrigo Company plc., Nanjing pharmaceutical factory Co. ltd., Trumac Healthcare, Globela Pharma Pvt Ltd., LNK International Inc., and Others.
Years considered for this report:
Historical Period: 2015- 2022
Base Year: 2023
Estimated Year: 2024
Forecast Period: 2025-2034
This report will be delivered on an online digital platform with one-year subscription and quarterly update.
Objective of the Study:
• To assess the demand-supply scenario of Aspirin which covers production, demand and supply of Aspirin market in the globe.
• To analyse and forecast the market size of Aspirin
• To classify and forecast Global Aspirin market based on end-use and regional distribution.
• To examine competitive developments such as expansions, mergers & acquisitions, etc., of Aspirin market in the globe.
To extract data for Global Aspirin market, primary research surveys were conducted with Aspirin manufacturers, suppliers, distributors, wholesalers and Traders. While interviewing, the respondents were also inquired about their competitors. Through this technique, ChemAnalyst was able to include manufacturers that could not be identified due to the limitations of secondary research. Moreover, ChemAnalyst analyzed various segments and projected a positive outlook for Global Aspirin market over the coming years.
ChemAnalyst calculated Aspirin demand across the globe by analyzing the volume of Aspirin consumed by the End-Use Applications and the forecast is calculated based on the growth rate of end-use industries. ChemAnalyst sourced these values from industry experts and company representatives and externally validated them by analyzing the historical sales data of respective manufacturers to determine the overall market size. Various secondary sources such as company websites, association reports, annual reports, etc., were also studied by ChemAnalyst.
Key Target Audience:
• Aspirin manufacturers and other stakeholders
• Organizations, forums and alliances related to Aspirin distribution
• Government bodies such as regulating authorities and policy makers
• Market research organizations and consulting companies
The study is useful in providing answers to several critical questions that are important for industry stakeholders such as Aspirin manufacturers, customers and policy makers. The study would also help them to target the growing segments over the coming years (next two to five years), thereby aiding the stakeholders in taking investment decisions and facilitating their expansion.
Report Scope:
In this report, Global Aspirin market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Attribute
Details
Market size Volume in 2023
41 thousand tonnes
Market size Volume in 2034
57 thousand tonnes
Growth Rate
CAGR of 2.5% from 2024 to 2034
Base year
2023
Estimated year
2024
Historical Data
2015 – 2022
Forecast period
2025 – 2034
Quantitative units
Demand in thousand tonnes and CAGR from 2024 to 2034
Report coverage
Industry Market Size, Capacity by Company, Capacity by Location, Operating Efficiency, Production by Company, Demand by Type, Demand by End-Use Application, Demand by Region, 9. Demand by Distribution Channel, Demand-Supply Gap, Company Share, Manufacturing Process.
Segments covered
By End-Use Application: (Pain and Fever, Cardiovascular Disease, and Others)
By Sales Channel: (Direct Sale and Indirect Sale)
Regional scope
North America, Europe, Asia Pacific, Middle East and Africa, and South America.
I am satisfied with overall performance of ChemAnalyst. Weekly updates before the final report were especially helpful and reassuring. Additional requests on the interim and/or final reports were handled in a swift and professional manner
Mr.Shin Dosho
Member - Board of Directors
Osaka Gas Co. Ltd
Disruption Tracker
Disruption Tracker reflect the major shutdown on monthly basis which will help you in
tracking the inventory management and smooth functioning of business. Unforeseen shutdowns and disruptions
resulting in a loss of production capacity to impact the bottom line. The capacity tracker provides industries
with a global view of production and consumption capacity loss that reflects the corresponding conversion factors.
It also highlights the immediate impact on supply due to planned and unplanned outages as well as upcoming start-up
of new capacities. Additionally, it emphasizes how each shutdown—whether due to a maintenance turnaround or a case
of force majeure, affects the plant's operating rate for the given duration. Disruption tracker gives a clear insight
into the worldwide outages affecting the commodity of interest. With every shutdown, it also reflects the impact on
supply of the product in the market at a Global level.
What was the net market size of Aspirin in terms of volume in 2023?
Ans:
The global market size of Aspirin has reached approximately 41 thousand tonnes in 2023.
Q2.
Which region is the leading consumer of Aspirin?
Ans:
Asia Pacific region is the leading consumer of Aspirin globally.
Q3.
Do you offer single or multiuser license?
Ans:
Online Access 12 Months – Single User License (Up to 3 users can access the database) Online Access 12 Months – Enterprise License (Up to 10 Users can access the database)
Q4.
Will I get access to the analyst who authored this report?
Ans:
You will have 24/7 access to the analyst during the subscription period.
Our Solutions
Custom Research
We at ChemAnalyst provide tailor-made solutions to our clients based on their requirements which help them in building and expanding their business by developing customized strategy such as sales strategy, GTM Strategy, product portfolio and new product development. Our dedicated team helps clients in getting the best solution for their requirements. We at ChemAnalyst look forward to serving our clients for long term association.
Techno Economic Feasibility Report (TEFR)
ChemAnalyst provide TEFR reports which include market sizing, plant cost (ISBL and OSBL units), financial modelling, covering all the major financial calculations and ratios including production cost, IRR, major technology, licensing fee (if required), and others fixed and variable costs. TEFR reports will help the client to build greenfield project as well as brownfield expansion for a specific geography. Our Team of experts have delivered multiple TEFR reports which help clients in moving ahead of their business competition by grabbing the opportunity and expanding their business portfolio.
Price Benchmarking
Pricing benchmark report provides real-time data perpetuating current market scenarios, in a world that is changing at a rapid pace, having real-time prices is an imperative to make impactful insights and thereby informed decisions. The Price Benchmarking report provides pricing data for an individual market, or group of markets, which can be converted into localized insights and comparable listings. Benchmarking Reports help clients to make informed decisions by construing the data on several filters: region, country, category, grade and subsequently increasing their brand presence. Clients majorly require pricing benchmarks when they opt for a competitive pricing strategy.